Brighton Jones LLC Purchases Shares of 3,402 HCA Healthcare, Inc. (NYSE:HCA)

Brighton Jones LLC bought a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,402 shares of the company’s stock, valued at approximately $1,021,000.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Legacy Investment Solutions LLC bought a new stake in HCA Healthcare in the third quarter valued at $39,000. Capital Performance Advisors LLP purchased a new position in shares of HCA Healthcare during the third quarter valued at about $41,000. Benjamin F. Edwards & Company Inc. bought a new stake in HCA Healthcare during the 2nd quarter valued at approximately $33,000. Canoe Financial LP purchased a new position in shares of HCA Healthcare in the 3rd quarter valued at approximately $41,000. Finally, Northwest Investment Counselors LLC purchased a new stake in HCA Healthcare in the third quarter worth $44,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Down 4.0 %

Shares of HCA stock opened at $312.51 on Friday. HCA Healthcare, Inc. has a 12 month low of $279.93 and a 12 month high of $417.14. The company has a 50 day simple moving average of $313.49 and a two-hundred day simple moving average of $352.62. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The stock has a market cap of $79.16 billion, a P/E ratio of 14.03, a P/E/G ratio of 1.09 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 520.98% and a net margin of 8.52%. During the same period in the previous year, the business earned $5.90 earnings per share. On average, research analysts expect that HCA Healthcare, Inc. will post 21.75 earnings per share for the current year.

Analyst Upgrades and Downgrades

HCA has been the subject of several research reports. TD Cowen decreased their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a research report on Tuesday, December 17th. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Truist Financial dropped their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, KeyCorp dropped their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $385.27.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.